Mankind Pharma Limited (NSE:MANKIND)
2,566.30
-0.90 (-0.04%)
Aug 1, 2025, 3:30 PM IST
Everi Holdings Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2021 |
129,099 | 122,074 | 102,604 | 87,494 | 77,816 | 62,144 | Upgrade | |
Revenue Growth (YoY) | 21.22% | 18.98% | 17.27% | 12.44% | 25.22% | 5.83% | Upgrade |
Cost of Revenue | 39,037 | 36,596 | 33,056 | 30,031 | 24,879 | 18,471 | Upgrade |
Gross Profit | 90,062 | 85,479 | 69,549 | 57,463 | 52,937 | 43,673 | Upgrade |
Selling, General & Admin | 36,271 | 34,734 | 28,830 | 23,126 | 20,934 | 18,195 | Upgrade |
Other Operating Expenses | 21,756 | 20,461 | 15,432 | 15,195 | 12,014 | 8,386 | Upgrade |
Operating Expenses | 65,399 | 61,408 | 48,047 | 41,580 | 34,614 | 27,770 | Upgrade |
Operating Income | 24,663 | 24,071 | 21,502 | 15,883 | 18,322 | 15,903 | Upgrade |
Interest Expense | -5,807 | -4,209 | -278.2 | -402.74 | -557.8 | -193.03 | Upgrade |
Interest & Investment Income | 679.1 | 679.1 | 396.1 | 127.67 | 129.25 | 387.27 | Upgrade |
Earnings From Equity Investments | 115 | 122.4 | 152.1 | 124.24 | 144.48 | 116.77 | Upgrade |
Currency Exchange Gain (Loss) | 195.5 | 195.5 | 84.4 | 104.06 | 88.45 | 5.02 | Upgrade |
Other Non Operating Income (Expenses) | 919.5 | 1,115 | 878.6 | 536.42 | 486 | 51.17 | Upgrade |
EBT Excluding Unusual Items | 20,765 | 21,974 | 22,735 | 16,372 | 18,613 | 16,270 | Upgrade |
Impairment of Goodwill | - | - | - | -38.52 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 1,608 | 1,608 | 1,295 | 374.31 | 1,129 | 628.65 | Upgrade |
Gain (Loss) on Sale of Assets | 1,614 | 1,614 | 4.8 | 16.65 | -37.41 | -30.45 | Upgrade |
Asset Writedown | -50.2 | -50.2 | -91.6 | -97.08 | -57.63 | -38.88 | Upgrade |
Other Unusual Items | 8.1 | 8.1 | 24.8 | 41.53 | 85.27 | 77.21 | Upgrade |
Pretax Income | 23,955 | 25,163 | 23,979 | 16,712 | 19,746 | 16,916 | Upgrade |
Income Tax Expense | 4,828 | 5,097 | 4,572 | 3,616 | 5,216 | 3,986 | Upgrade |
Earnings From Continuing Operations | 19,127 | 20,066 | 19,408 | 13,097 | 14,530 | 12,930 | Upgrade |
Earnings From Discontinued Operations | -0.6 | 45.3 | 9.8 | - | - | - | Upgrade |
Net Income to Company | 19,127 | 20,111 | 19,418 | 13,097 | 14,530 | 12,930 | Upgrade |
Minority Interest in Earnings | -198.8 | -201.6 | -288.7 | -278.17 | -194.81 | -276.07 | Upgrade |
Net Income | 18,928 | 19,910 | 19,129 | 12,819 | 14,335 | 12,654 | Upgrade |
Net Income to Common | 18,928 | 19,910 | 19,129 | 12,819 | 14,335 | 12,654 | Upgrade |
Net Income Growth | -3.55% | 4.08% | 49.23% | -10.58% | 13.28% | 22.81% | Upgrade |
Shares Outstanding (Basic) | 407 | 404 | 401 | 401 | 401 | 401 | Upgrade |
Shares Outstanding (Diluted) | 408 | 405 | 401 | 401 | 401 | 401 | Upgrade |
Shares Change (YoY) | 1.63% | 0.88% | 0.14% | 0.00% | - | - | Upgrade |
EPS (Basic) | 46.51 | 49.28 | 47.75 | 32.00 | 35.78 | 31.59 | Upgrade |
EPS (Diluted) | 46.42 | 49.19 | 47.68 | 32.00 | 35.78 | 31.59 | Upgrade |
EPS Growth | -5.10% | 3.16% | 49.02% | -10.57% | 13.27% | 22.82% | Upgrade |
Free Cash Flow | - | 19,526 | 18,371 | 10,243 | 4,549 | 8,318 | Upgrade |
Free Cash Flow Per Share | - | 48.25 | 45.79 | 25.57 | 11.36 | 20.77 | Upgrade |
Gross Margin | 69.76% | 70.02% | 67.78% | 65.68% | 68.03% | 70.28% | Upgrade |
Operating Margin | 19.10% | 19.72% | 20.96% | 18.15% | 23.55% | 25.59% | Upgrade |
Profit Margin | 14.66% | 16.31% | 18.64% | 14.65% | 18.42% | 20.36% | Upgrade |
Free Cash Flow Margin | - | 16.00% | 17.90% | 11.71% | 5.85% | 13.38% | Upgrade |
EBITDA | 31,034 | 29,898 | 25,152 | 19,051 | 19,910 | 17,038 | Upgrade |
EBITDA Margin | 24.04% | 24.49% | 24.51% | 21.77% | 25.59% | 27.42% | Upgrade |
D&A For EBITDA | 6,371 | 5,827 | 3,649 | 3,168 | 1,588 | 1,135 | Upgrade |
EBIT | 24,663 | 24,071 | 21,502 | 15,883 | 18,322 | 15,903 | Upgrade |
EBIT Margin | 19.10% | 19.72% | 20.96% | 18.15% | 23.55% | 25.59% | Upgrade |
Effective Tax Rate | 20.15% | 20.26% | 19.06% | 21.63% | 26.42% | 23.56% | Upgrade |
Revenue as Reported | 134,272 | 127,442 | 105,407 | 88,780 | 79,776 | 63,854 | Upgrade |
Advertising Expenses | - | 7,554 | 6,008 | 3,737 | 4,516 | 3,857 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.